MENU

FOLD Amicus Therapeutics Forecast, Technical & Fundamental Analysis

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FOLD is expected to report earnings to fall 87.00% to 1 cents per share on February 26

Amicus Therapeutics FOLD Stock Earnings Reports
Q4'24
Est.
$0.01
Q3'24
Beat
by $0.10
Q2'24
Est.
$-0.05
Q1'24
Beat
by $0.04
Q4'23
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of 10 cents, beating the estimate of 0 cents. With 1.12M shares outstanding, the current market capitalization sits at 2.96B.
A.I. Advisor
published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

FOLD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with ALDX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.10%
ALDX - FOLD
46%
Loosely correlated
+5.34%
RCKT - FOLD
43%
Loosely correlated
+1.36%
DNLI - FOLD
41%
Loosely correlated
-0.30%
ROIV - FOLD
41%
Loosely correlated
+0.41%
PGEN - FOLD
40%
Loosely correlated
+2.46%
More